MHRA Drug Safety Update July 2022
Links to the MHRA Drug Safety Update for July 2022 are listed below.
- Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure
- COVID-19 vaccines and medicines: updates for July 2022
- Letters and medicine recalls sent to healthcare professionals in June 2022
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published 25/07/2022. Medicines Update blogs are correct at the time of publication.